IN2014DN08588A - - Google Patents

Info

Publication number
IN2014DN08588A
IN2014DN08588A IN8588DEN2014A IN2014DN08588A IN 2014DN08588 A IN2014DN08588 A IN 2014DN08588A IN 8588DEN2014 A IN8588DEN2014 A IN 8588DEN2014A IN 2014DN08588 A IN2014DN08588 A IN 2014DN08588A
Authority
IN
India
Prior art keywords
1himidazol
benzenamine
trifluoromethyl
safe
prepare
Prior art date
Application number
Other languages
English (en)
Inventor
Stephan Abel
Murat Acemoglu
Bernhard Erb
Christoph Krell
Joseph Sclafani
Mark Meisenbach
Mahavir Prashad
Wen-Chung Shieh
Song Xue
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37149980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN08588(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IN2014DN08588A publication Critical patent/IN2014DN08588A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
IN8588DEN2014 2005-06-09 2006-06-07 IN2014DN08588A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68897605P 2005-06-09 2005-06-09
PCT/US2006/022154 WO2006135640A2 (fr) 2005-06-09 2006-06-07 Procede de synthese de composes organiques

Publications (1)

Publication Number Publication Date
IN2014DN08588A true IN2014DN08588A (fr) 2015-07-10

Family

ID=37149980

Family Applications (2)

Application Number Title Priority Date Filing Date
IN8588DEN2014 IN2014DN08588A (fr) 2005-06-09 2006-06-07
IN8578DEN2014 IN2014DN08578A (fr) 2005-06-09 2006-06-07

Family Applications After (1)

Application Number Title Priority Date Filing Date
IN8578DEN2014 IN2014DN08578A (fr) 2005-06-09 2006-06-07

Country Status (25)

Country Link
US (2) US7781597B2 (fr)
EP (3) EP1896426B1 (fr)
JP (2) JP5225078B2 (fr)
KR (2) KR101283109B1 (fr)
CN (6) CN102174020B (fr)
AR (1) AR057056A1 (fr)
AT (1) ATE540931T1 (fr)
AU (3) AU2006258050B2 (fr)
BR (1) BRPI0611683A2 (fr)
CA (4) CA2611280C (fr)
DK (2) DK2292607T3 (fr)
ES (3) ES2380489T3 (fr)
GT (1) GT200600202AA (fr)
HU (1) HUE028024T2 (fr)
IN (2) IN2014DN08588A (fr)
JO (1) JO2758B1 (fr)
MX (1) MX2007015609A (fr)
MY (1) MY146795A (fr)
PE (3) PE20100716A1 (fr)
PL (3) PL2266961T3 (fr)
PT (3) PT1896426E (fr)
RU (1) RU2446162C2 (fr)
SI (2) SI2292607T1 (fr)
TW (1) TWI380981B (fr)
WO (1) WO2006135640A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2526614T3 (es) 2004-03-05 2015-01-13 Nissan Chemical Industries, Ltd. Compuesto de benzamida sustituida con isoxazolina y agente de control de organismos nocivos
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
MX2009013469A (es) 2007-06-13 2010-01-20 Du Pont Insecticidas de isoxazolina.
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
MX368680B (es) 2007-06-27 2019-10-11 Du Pont Administración subcutánea de un derivado de isoxazol-benzamida para usarse en un método para proteger un mamífero de una pulga.
TWI461411B (zh) 2007-08-17 2014-11-21 Du Pont 製備５－鹵烷基－４，５－二氫異唑衍生物之方法
MX2010003557A (es) 2007-10-03 2010-04-12 Du Pont Compuestos de isoxazolina de naftaleno para el control de plagas de invertebrados.
TWI455919B (zh) * 2008-04-09 2014-10-11 Du Pont 製備３－三氟甲基查耳酮（ｃｈａｌｃｏｎｅ）之方法
WO2010009402A2 (fr) * 2008-07-17 2010-01-21 Teva Pharmaceutical Industries Ltd. Intermédiaires de nilotinib, et leur préparation
ES2394258T3 (es) 2008-11-05 2013-01-30 Teva Pharmaceutical Industries Ltd. Formas cristalinas de Nilotinib HCL
WO2010060074A1 (fr) * 2008-11-24 2010-05-27 Teva Pharmaceutical Industries Ltd. Synthèse du nilotinib et ses intermédiaires
US20110053968A1 (en) 2009-06-09 2011-03-03 Auspex Pharmaceuticals, Inc. Aminopyrimidine inhibitors of tyrosine kinase
CA2799963C (fr) 2010-05-27 2018-01-23 E. I. Du Pont De Nemours And Company Forme cristalline du 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphtalenecarboxamide
RU2705577C2 (ru) 2011-12-30 2019-11-08 Ханми Фарм. Ко., Лтд. ПРОИЗВОДНЫЕ ТИЕНО[3,2-d]ПИРИМИДИНА, ОБЛАДАЮЩИЕ ИНГИБИРУЮЩЕЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ ПРОТЕИНКИНАЗ
CN102592837B (zh) * 2012-03-12 2014-01-15 河北师范大学 制备超级电容器用四氯合金属季铵盐掺杂聚苯胺电极的方法
CN103694176B (zh) 2014-01-07 2015-02-18 苏州立新制药有限公司 尼洛替尼中间体的制备方法
CN104592122B (zh) * 2014-12-09 2018-01-23 凯莱英医药集团（天津）股份有限公司 3‑(4‑甲基‑1h‑咪唑‑1‑基)‑5‑(三氟甲基)苯胺的制备方法
CN105985293B (zh) * 2015-03-04 2018-04-03 埃斯特维华义制药有限公司 尼洛替尼中间体的制备方法
EP3095782A1 (fr) 2015-05-18 2016-11-23 Esteve Química, S.A. Nouveau procédé de préparation de 3- (4-methyl-1h-imidazol-1-yl) -5- (trifluorométhyl) benzénamine
CN107201532B (zh) * 2017-05-09 2019-08-27 吉林凯莱英医药化学有限公司 芳香化合物的硝化方法
US11053220B2 (en) 2018-01-01 2021-07-06 Laurus Labs Ltd Process for 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl) aniline
CN108530364B (zh) 2018-04-10 2020-01-21 江苏创诺制药有限公司 一种3-(4-甲基-1h-咪唑-1-基)-5-三氟甲基苯胺单盐酸盐的晶型及其应用
TWI815137B (zh) 2018-06-15 2023-09-11 漢達生技醫藥股份有限公司 尼洛替尼十二烷基硫酸鹽之結晶
CA3136189A1 (fr) * 2019-04-06 2020-10-15 Trinapco, Inc. Sulfonyldiazoles et n-(fluorosulfonyl)azoles, et leurs procedes de preparation
EP3904342A1 (fr) 2020-04-28 2021-11-03 Grindeks, A Joint Stock Company Procédé de préparation de 3-(trifluorométhyl)-5-(4-méthyl-1h-imidazole-1-yl)-benzèneamine hydrochlorure
CN114751836A (zh) * 2021-02-23 2022-07-15 成都硕德药业有限公司 3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺合成方法及其中间体
CN114853734A (zh) * 2022-06-14 2022-08-05 海南鑫开源医药科技有限公司 一种尼洛替尼游离碱的制备方法
CN115626880B (zh) * 2022-11-15 2023-11-14 常州大学 3-硝基-5-氰基三氟甲苯的合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1051076A1 (ru) * 1982-04-09 1983-10-30 Алтайский политехнический институт Способ получени производных имидазола
GB8413685D0 (en) * 1984-05-29 1984-07-04 Pfizer Ltd Quinolone inotropic agents
NZ212209A (en) * 1984-05-29 1988-08-30 Pfizer Quinolone derivatives and pharmaceutical compositions
GB8502267D0 (en) * 1985-01-30 1985-02-27 Pfizer Ltd Quinolone inotropic agents
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
GB0023383D0 (en) * 2000-09-23 2000-11-08 Synprotec Ltd 3,5-Bis (Trifluormethyl)Benzene derivatives
AR037647A1 (es) 2002-05-29 2004-12-01 Novartis Ag Derivados de diarilurea utiles para el tratamiento de enfermedades dependientes de la cinasa de proteina
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds
GB0222514D0 (en) 2002-09-27 2002-11-06 Novartis Ag Organic compounds
CN1939910A (zh) * 2004-12-31 2007-04-04 孙飘扬 氨基嘧啶类化合物及其盐和其制备方法与药物用途
GT200600207A (es) * 2005-06-09 2007-01-15 Novartis Ag Proceso para la síntesis de compuestos orgánicos
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds

Also Published As

Publication number Publication date
RU2007148238A (ru) 2009-07-20
CA2833394A1 (fr) 2006-12-21
KR101283109B1 (ko) 2013-07-05
SI2292607T1 (sl) 2014-09-30
PT2266961E (pt) 2016-02-05
US20080200692A1 (en) 2008-08-21
PL1896426T3 (pl) 2012-06-29
ES2380489T3 (es) 2012-05-14
AR057056A1 (es) 2007-11-14
DK2266961T3 (en) 2016-01-25
ES2380489T8 (es) 2012-06-22
AU2010241374A1 (en) 2010-12-02
AU2011201044A1 (en) 2011-03-31
GT200600202AA (es) 2014-06-09
CA2611280A1 (fr) 2006-12-21
PL2292607T3 (pl) 2014-09-30
WO2006135640A2 (fr) 2006-12-21
IN2014DN08578A (fr) 2015-07-10
ES2558696T3 (es) 2016-02-08
PE20070109A1 (es) 2007-04-02
CN102174021B (zh) 2013-02-27
US20100280257A1 (en) 2010-11-04
CN102174020A (zh) 2011-09-07
CN102180836B (zh) 2012-11-21
PT2292607E (pt) 2014-06-24
EP2292607A3 (fr) 2011-04-27
PT1896426E (pt) 2012-04-12
AU2010241374B2 (en) 2011-11-03
EP1896426B1 (fr) 2012-01-11
JO2758B1 (en) 2014-03-15
PL2266961T3 (pl) 2016-04-29
CN101189212A (zh) 2008-05-28
CN102174020B (zh) 2012-11-07
CA2942046A1 (fr) 2006-12-21
AU2006258050B2 (en) 2010-12-09
AU2006258050A1 (en) 2006-12-21
CN101189212B (zh) 2011-05-18
TWI380981B (zh) 2013-01-01
DK2292607T3 (da) 2014-06-30
CA2886482C (fr) 2017-09-05
US8008504B2 (en) 2011-08-30
WO2006135640A3 (fr) 2007-08-02
EP2292607B1 (fr) 2014-04-09
JP2008546645A (ja) 2008-12-25
CN102180796A (zh) 2011-09-14
EP1896426A2 (fr) 2008-03-12
CN102174019B (zh) 2013-02-13
CA2886482A1 (fr) 2006-12-21
EP2266961B1 (fr) 2015-10-21
EP2292607A2 (fr) 2011-03-09
CA2833394C (fr) 2016-03-29
CN102180836A (zh) 2011-09-14
MY146795A (en) 2012-09-28
ES2465522T3 (es) 2014-06-06
KR20080014010A (ko) 2008-02-13
RU2446162C2 (ru) 2012-03-27
JP5225078B2 (ja) 2013-07-03
KR20120099028A (ko) 2012-09-06
TW200716563A (en) 2007-05-01
JP2013035855A (ja) 2013-02-21
HUE028024T2 (en) 2016-11-28
KR101249199B1 (ko) 2013-04-03
PE20100716A1 (es) 2010-10-25
BRPI0611683A2 (pt) 2010-09-28
MX2007015609A (es) 2008-02-25
PE20100715A1 (es) 2010-10-25
CA2611280C (fr) 2014-01-28
EP2266961A3 (fr) 2011-07-27
CN102174019A (zh) 2011-09-07
EP2266961A2 (fr) 2010-12-29
CN102174021A (zh) 2011-09-07
SI2266961T1 (sl) 2016-02-29
US7781597B2 (en) 2010-08-24
ATE540931T1 (de) 2012-01-15

Similar Documents

Publication Publication Date Title
IN2014DN08588A (fr)
WO2009016462A3 (fr) Bicyclolactames substitués
UA93910C2 (ru) Алкоксиалкилзамещенные циклические кетоэнолы и средство для борьбы c вредителями
WO2007085895A3 (fr) Inhibiteurs fap
TW200626559A (en) Anilino-pyrimidine analogs
WO2007105058A8 (fr) Pyrazoles
MX2007011023A (es) 2-(4-oxo-4h-quinazolin-3-il) acetamidas y su uso como antagonistas de vasopresin v3.
TW200624426A (en) BACE inhibitors
EP1740559A4 (fr) Derives de phenyle 1,3,5-substitues utiles comme inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer
GB0510143D0 (en) Novel compounds A1
WO2005087724A3 (fr) Nouvelles hydroxy-6-phenylphenanthridines a substitution amido
TW200710084A (en) Process for the synthesis of organic compounds
MX2010002938A (es) Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer.
TW200745039A (en) Isotopically substituted pantoprazole
DK1696905T3 (da) Substituerede 2-aminotetraliner til forebyggende behandling af Morbus Parkinson
WO2007022947A3 (fr) Composes 5-cycle-heteroaromates et leur utilisation en tant que partenaires de liaison des recepteurs 5-ht5
WO2007019191A3 (fr) Inhibiteurs de la thiazolopyrimidine kinase
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
WO2007062308A3 (fr) Inhibiteurs de cetp heterocycliques
MY145788A (en) Antitumoral dihydropyran-2-one compounds
WO2006134499A3 (fr) Derives de 2-(1h-indolylsulfanyl)-aryl amine
MX2010007543A (es) Inhibidores de iap.
TNSN06260A1 (en) Process for the preparation of tryptase inhibitors
WO2008019030A3 (fr) Composés d'azole modifiés en tant qu'agents anti-infectieux
WO2006023586A3 (fr) Composes de guanylhydrazone, compositions de guanylhydrazone, ainsi que leurs methodes de fabrication